MEDVi is a doctor-led telehealth weight loss program in the USA that combines GLP-1 medications like semaglutide and tirzepatide with personalized medical support. It is designed to help adults achieve sustainable fat loss safely and effectively, without long clinic visits or insurance hassles.
MEDVi works by pairing medically approved GLP-1 therapy with personalized plans. Users complete a quick online assessment, receive guidance from licensed clinicians, and choose between weekly injections or daily tablets. Medication is delivered directly to your door, and 24/7 support is provided to track progress and manage side effects.
Initial pricing for MEDVi starts at $179 for weekly injections and $249 for daily tablets. Monthly refills typically range from $299–$399, depending on the medication format, with all telehealth consultations and shipping included.
Most users notice changes in appetite and portion control within the first few weeks. Steady weight loss of 10–20% of starting body weight is common over several months when following the plan consistently.
Absolutely. MEDVi offers weekly GLP-1 injections for convenience or daily tablets for those averse to needles or who travel frequently. Plans can be adjusted anytime based on lifestyle preferences.
No. MEDVi is a cash-pay service, with transparent pricing and no hidden fees. Brand-name options like Ozempic® are available but may cost more. Compounded GLP-1 medications provide an affordable alternative.


